Thalys Medical Technology Group Corporation (603716.SH) released its third quarter report for 2024, with revenue for the first three quarters of the company at 14...
Finance and Economics APP News, Thalys Medical Technology Group Corporation (603716.SH) released its third quarter report for 2024, with revenue for the first three quarters of the company at 1.42 billion yuan, a year-on-year decrease of 7.15%; net loss attributable to shareholders of the listed company was 56.0251 million yuan; net loss attributable to shareholders of the listed company after deducting non-recurring gains and losses was 26.1117 million yuan; basic loss per share was 0.28 yuan/share.